The treatment of hepatic metastases from colorectal cancer with radiation therapy alone or combined with chemotherapy or misonidazole Journal Article


Authors: Minsky, B. D.; Leibel, S. A.
Article Title: The treatment of hepatic metastases from colorectal cancer with radiation therapy alone or combined with chemotherapy or misonidazole
Abstract: In summary, whole liver RT alone is generally well tolerated and, in most cases, offers some palliative benefit. It is difficult to determine its ultimate impact on survival since many patients treated with this single modality have extra-hepatic disease. In addition, the dose of radiation which the liver can tolerate is not adequate to control gross disease. The addition of chemotherapy (systemic and/or intra-hepatic) appears promising. However, further follow-up and randomized trials need to be performed before this is known with certainty. The use of misonidazole in the dosages and techniques employed by the RTOG did not appear to enhance overall survival. More innovative techniques of delivering RT, including intraoperative brachytherapy, radiolabeled antibodies, and hyperfractionated external beam RT require further investigation in order to determine their efficacy. © 1989.
Keywords: review; doxorubicin; fluorouracil; multimodality cancer therapy; liver neoplasms; cancer radiotherapy; combined modality therapy; antineoplastic agent; colorectal cancer; colorectal neoplasms; liver metastasis; randomized controlled trials; misonidazole; floxuridine; intravenous drug administration; human; priority journal
Journal Title: Cancer Treatment Reviews
Volume: 16
Issue: 4
ISSN: 0305-7372
Publisher: Elsevier Inc.  
Date Published: 1989-12-01
Start Page: 213
End Page: 219
Language: English
DOI: 10.1016/0305-7372(89)90042-x
PUBMED: 2700316
PROVIDER: scopus
DOI/URL:
Notes: Article -- Export Date: 14 April 2020 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Bruce Minsky
    306 Minsky
  2. Steven A Leibel
    252 Leibel